MONETA GROUP INVESTMENT ADVISORS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1120927
ST LOUIS, MO
Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$369,321
+$39,733 QoQ
Shares Held
478
+11.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $1,862,709 across 8 Biotechnology names. REGN ranks #3 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
996 | $444,753 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,307 | $388,139 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
478 | $369,321 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
9,399 | $285,729 | |
| 5 | CADL |
Candel Therapeutics, Inc.
|
41,867 | $205,148 | |
| 6 | ABUS |
Arbutus Biopharma Corp
|
26,000 | $117,000 | |
| 7 | ALXO |
Alx Oncology Holdings Inc
|
15,196 | $30,467 | |
| 8 | LGVN |
Longeveron Inc.
|
21,300 | $22,152 |
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $369,321 | 478 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $329,588 | 427 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $249,085 | 443 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $236,250 | 450 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $501,041 | 790 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $534,959 | 751 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $901,963 | 858 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $879,712 | 837 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $652,568 | 678 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $499,747 | 569 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $469,910 | 571 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $412,441 | 574 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $528,333 | 643 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $372,288 | 516 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $692,314 | 1,005 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $595,267 | 1,007 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $386,924 | 554 | Shares | Sole | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||